Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
03/06/202407:08Edgar (US Regulatory)Form 8-K - Current reportNYSE:MCKMcKesson Corporation
03/06/202407:07PR Newswire (US)Ophthalmic Care and Diagnostics Methods Patents Available on the Ocean Tomo Bid-Ask Market® Platform
03/06/202407:07GlobeNewswire Inc.Four Charlesbank Portfolio Companies Named to Newsweek’s “America’s Greatest Workplaces for Mental Wellbeing 2024”
03/06/202407:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ENLVEnlivex Therapeutics Ltd
03/06/202407:05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:SYFSynchrony Financiall
03/06/202407:05GlobeNewswire Inc.InnovAge PACE Recertified as a Great Place to WorkNASDAQ:INNVInnovAge Holding Corporation
03/06/202407:05Business WireKelley Shaw Joins Alliant Employee Benefits, Will Service Diverse Southeast Client Base
03/06/202407:05PR Newswire (US)Waters Sets New Standards for High Resolution Performance and Speed with Xevo MRT Mass SpectrometerNYSE:WATWaters Corp
03/06/202407:05PR Newswire (US)V2X announces successful repricing and extension of Term LoanNYSE:VVXV2X Inc
03/06/202407:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:LPTVLoop Media Inc
03/06/202407:04Business WireHyatt’s Growth Momentum Continues With Record Global Pipeline of 129,000 RoomsNYSE:HHyatt Hotels Corporation
03/06/202407:04PR Newswire (US)TÜV Rheinland's Northeast Technology & Innovation Center receive accreditation to verify equipment to be imported into Korea and other significant accreditations
03/06/202407:04GlobeNewswire Inc.Noom Launches Noom Vibe, a Wellness Community and Habit Tracker Built for the Age of GLP-1s
03/06/202407:03Alliance NewsAlliance NewsFranchise Brands sees top-end 2023 earnings and plans dividend boostLSE:FRANFranchise Brands Plc
03/06/202407:03Business WireGrace Science, LLC Selected by FDA to Participate in the START Pilot Program for GS-100 Gene Therapy for NGLY1 Deficiency and Announcement of the Successful Treatment of the 2nd Patient
03/06/202407:03PR Newswire (Canada)U.S.-based Lithium Producer International Battery Metals (IBAT) Names Iris Jancik as CEO to Lead Global Commercial Expansion
03/06/202407:02GlobeNewswire Inc.Ready Capital to Present at Nareit’s REITweek 2024NYSE:RCReady Capital Corporation 65
03/06/202407:02GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferenceNASDAQ:RYTMRhythm Pharmaceuticals Inc
03/06/202407:02PR Newswire (US)MIT Sloan Management Review Research Examines Circular Business Models' Benefit to Bottom Line and Increased Sustainability Measures
03/06/202407:01GlobeNewswire Inc.Texas Must Close Primary Elections
03/06/202407:01ZyCryptoOver $3 Billion In Ether Leaves Exchanges as Whale Accumulation SoarsCOIN:FETUSDFetch
03/06/202407:01Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:RFACWRF Acquisition Corporation
03/06/202407:01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FUTUFutu Holdings Ltd
03/06/202407:01GlobeNewswire Inc.Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024NASDAQ:MYNZMainz BioMed NV
03/06/202407:01PR Newswire (US)Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesNASDAQ:AEMDAethlon Medical Inc
03/06/202407:01PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - OPTI
03/06/202407:01PR Newswire (US)Neurocrine Biosciences Presented CAHtalyst™ Phase 3 Pediatric and Adult Studies, CAHtalog™ Registry and Disease- and Glucocorticoid-Related Comorbidities Data in CAH at ENDO 2024NASDAQ:NBIXNeurocrine Biosciences Inc
03/06/202407:00GlobeNewswire Inc.Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following Treatment with Bizaxofusp When Compared to a Matched External Control Arm at the 2024 ASCO Annual MeetingTSX:MDNAMedicenna Therapeutics Corp
03/06/202407:00GlobeNewswire Inc.Genesis Offers New Tools and Incentives to Financial Industry Software Developers
03/06/202407:00GlobeNewswire Inc.Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease TherapiesNASDAQ:DNLIDenali Therapeutics Inc

Su Consulta Reciente

Delayed Upgrade Clock